- Alimohamadi S.M., Ghodsi S.M., Ketabchi S.E. 2008. Epidemiologic patterns of primary brain tumors in Iran. Asian Pac Journal of Cancer Preview, 9(2): 361-372.
- Butowski N.A., Sneed P.K., Chang S.M. 2006. Diagnosis and treatment of recurrent high-grade astrocytoma. Journal of clinical oncology. 24(8): 1273-1280.
- Calabrese C., Poppleton H., Kocak Fuller C., Hamner B., Oh EY., Gaber MW., Finklestein D., Allen M., Frank A. 2007. A perivascular niche for brain tumor stem cells. Cancer cell. 11(1): 69-82.
- Feng X.D., Song Q., Li C.W., Chen J., Tang H.M., Peg Z.H., Wang X.C. 2014. Structural maintenance of chromosomes 4 is a predictor of survival and a novel therapeutic target in colorectal cancer. Asian Pacific Journal of Cancer Prevention,15(21): 9459-9465.
- Gabayan AJ., Green SB., Sanan A., Jenrette J., Schultz C., Papagikos M., Tatter SP., Patel A., Amin P., Lustig R., Bastin KT. 2006. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Neurosurgery, 58(4): 701-709.
- Jiang L., Zhou J., Zhong D., Zhou Y., Zhang W., Wu W., Zhao Z., Wang W., Xu W., He L., Ma Y. 2017. Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells. Oncogenesis, 6(3): e301-.
- Jinushi T., Shibayama Y., Kinoshita I., Oizumi S., Jinushi M., Aota T., Takahashi T., Horita S., Dosaka‐Akita H., Iseki K. 2014. Low expression levels of micro RNA‐124‐5p correlated with poor prognosis in colorectal cancer via targeting of SMC 4. Cancer Medicine, 3(6): 1544-1552.
- Kanehisa M., Goto S. 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Research, 28(1): 27-30.
- Kavsan V., Shostak K., Dmitrenko V., Zozulya Y., Rozumenko V., Demotes-Mainard J. 2005. Characterization of genes with increased expression in human glioblastomas. Tsitologiia i Genetika, 39(6): 37-49.
- Kheiri Manjili H., Ma’mani L., Tavaddod S., Mashhadikhan M., Shafiee A., Naderi-Manesh H. 2016. L-sulforaphane loaded Fe3O4@ gold core shell nanoparticles: a potential sulforaphane delivery system. PloS one, 11(3): e0151344.
- Ma R.M., Yang F., Huang D.P., Zheng M., Wang Y.L. 2019. The prognostic value of the expression of SMC4 mRNA in breast cancer. Disease Markers, 2019:2183057
- Mehrazin M., Rahmat H., Yavari P. 2006. Epidemiology of primary intracranial tumors in Iran, 1978-2003. Asian Pacific Journal of Cancer Prevention, 7(2): 283.
- Monfared H., Jahangard Y., Nikkhah M., Mirnajafi-Zadeh J., Mowla S.J. 2019. Potential therapeutic effects of exosomes packed with a miR-21-sponge construct in a rat model of glioblastoma. Frontiers in Oncology, 9: 782.
- Ostrom Q.T., Gittleman H., Fulop J., Liu M., Blanda R., Kromer C., Wolinsky Y., Kruchko C., Barnholtz-Sloan J.S. 2015. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro-oncology, 17(suppl-4): iv1-62.
- Roesler R., Brunetto A.T., Abujamra A.L., de Farias C.B., Brunetto A.L., Schwartsmann G. 2010. Current and emerging molecular targets in glioma. Expert Review of Anticancer Therapy, 10(11): 1735-1751.
- Röhn G., Koch A., Krischek B., Stavrinou P., Goldbrunner R., Timmer M. 2018. ACTB and SDHA are suitable endogenous reference genes for gene expression studies in human astrocytomas using quantitative RT-PCR. Technology in Cancer Research and Treatment, 17:1533033818802318.
- Sciumè G., Santoni A., Bernardini G. 2010. Chemokines and glioma: invasion and more. Journal of Neuroimmunology, 224(1-2): 8-12.
- See S.J., Gilbert M.R. 2004. Anaplastic astrocytoma: diagnosis, prognosis, and management. InSeminars in Oncology, 31(5): 618-634
- Stupp R., Mason W.P., Van Den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England journal of Medicine, 352(10): 987-996.
- Waghmare I., Roebke A., Minata M., Kango-Singh M., Nakano I. 2014. Intercellular cooperation and competition in brain cancers: lessons from Drosophila and human studies. Stem Cells Translational Medicine. 3(11): 1262-1268.
- Wu A., Wei J., Kong L.Y., Wang Y., Priebe W., Qiao W., Sawaya R., Heimberger A.B. 2010. Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro-oncology, 12(11): 1113-1125.
- Zhao S.G., Evans J.R., Kothari V., Sun G., Larm A., Mondine V., Schaeffer E.M., Ross A.E., Klein E.A., Den R.B., Dicker A.P. 2016. The landscape of prognostic outlier genes in high-risk prostate cancer. Clinical Cancer Research, 22(7):1777-1786.
- Zhou B., Chen H., Wei D., Kuang Y., Zhao X., Li G., Xie J., Chen P. 2014. A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinoma. Journal of Experimental and Clinical Cancer, 33(1): 55.
- Zhou B., Yuan T., Liu M., Liu H., Xie J., Shen Y., Chen P. 2012. Overexpression of the structural maintenance of chromosome 4 protein is associated with tumor de-differentiation, advanced stage and vascular invasion of primary liver cancer. Oncology Reports, 28(4): 1263-1268.
- Zhu T.S., Costello M.A., Talsma C.E., Flack C.G., Crowley J.G., Hamm L.L., He X., Hervey-Jumper S.L., Heth J.A., Muraszko K.M., DiMeco F. 2011. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Research, 71(18): 6061-6072
|
